Pfizer files Tygacil patent claim against Accord

16-02-2016

Pfizer files Tygacil patent claim against Accord

360b / Shutterstock.com

Accord Healthcare’s attempt to market a generic version of Pfizer’s Tygacil (tigecycline) has hit a brick wall after it was accused of infringing three patents.


Pfizer; Accord; Tygacil; US District Court for the District of Delaware; NDA;

LSIPR